EndoBridge 2019: Seventh Year of Solidarity in the World of Hormones

EB 2019 LOGO

The seventh annual meeting of EndoBridge® took place October 24-27, 2019 in Antalya, Turkey, co-hosted by the Endocrine Society and European Society of Endocrinology in collaboration with the Society of Endocrinology and Metabolism of Turkey.

The meeting was held in English with simultaneous translation into Russian, Arabic, and Turkish and accredited by the European Accreditation Council for Continuing Medical Education (EACCME). The three-day scientific program included state-of-the-art lectures by world-renown experts and interactive discussion sessions of challenging and interesting clinical cases covering all aspects of endocrinology.

“This conference epitomizes ‘bridging’ the practice of endocrinology from all corners of the planet to advance clinical practice and patient outcomes.”

“We had 680 delegates from 41 countries and over 100 case presentations this year,” says Bulent Yildiz, MD, a faculty member at Hacettepe University School of Medicine in Ankara, Turkey, and the founder and president of EndoBridge®. “As usual, the meeting provided excellent opportunities for learning, collaboration and networking in a welcoming environment. Our annual meeting has now become one of the highlights of the year in the hormone world.”

EndoBridge 2019 Faculty

According to Christopher Urena, the Endocrine Society’s chief learning officer, EndoBridge 2019 was an incredible opportunity to collaborate with and learn from colleagues across the globe. “This conference epitomizes ‘bridging’ the practice of endocrinology from all corners of the planet to advance clinical practice and patient outcomes,” he says. “We’re a global community committed to a common cause and together we stand united and strong.”

The eighth EndoBridge® will be held in Antalya, Turkey, October 22-25, 2020. Further information can be found at www.endobridge.org.

EndoBridge 2019 attendees and faculty

You may also like

  • Individuals Taking Class of Steroid Medications at High Risk for COVID-19

    JCEM Editors examine pandemic’s impact on endocrine patients in editorial Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according…

  • Endocrine Society Elects Wysham as 2021-2022 President

    Five endocrinologists to join Board of Directors Endocrine Society members have elected Carol H. Wysham, MD, to serve as the organization’s President for the 2021-2022 term. Wysham is an endocrinologist at Rockwood/MultiCare Health Systems in Spokane, Wash., and Clinical Professor of Medicine at the University of Washington. She will serve as President-Elect for a year…